David Bentley
(Illumina)
http://www.illumina.com/

David Bentley is Vice President and Chief Scientist at Illumina Inc., developing new DNA sequencing technology for fast, accurate sequencing of complex genomes. His research interests include the study of human sequence variation in health and disease. He was previously at the Wellcome Trust Sanger Institute. As a founding Member of the Board of Management and Head of Human Genetics, he played leading roles the Human Genome Project, The International SNP Consortium and the International HapMap Project. He is a Fellow of the Academy of Medical Sciences and a life member of the African Society of Human Genetics.